Treatment of Pilonidal Cyst With Holmium Laser

Pilonidal Cyst Clinical Trial

— PILOLAS  

Official title:

Treatment of Pilonidal Cyst With Holmium Laser

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05513898
• Other study ID #: COS-RGDS-2020-06-028-
• Status: Recruiting
• Start date: April 1, 2022
• Est. completion date: January 31, 2023

Study information

• Verified date: June 2022
• Source: GCS Ramsay Santé pour l'Enseignement et la Recherche
• Contact: Benjamin DARNIS, MD
• Phone: 04-37-49-66-77
• Email: benjamin.darnis[@]hotmail.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Observational study on the treatment of pilonidal cyst with Holmium laser. Single-centre retrospective study of medical data from patients' medical records

Description:

From the medical records of a series of patients treated for pilonidal cysts with Holmium laser:

1. Primary objective: to assess the rate of healing at 1 month after Holmium laser treatment (healing being defined as no dressing)

2. Secondary objectives: to assess the following:

• Healing rate at last follow-up (1 month after surgery)

• Recurrence rate at last follow-up (1 month after surgery)

• Consumption of >1 level analgesics in the week and month following the procedure

• Duration of nursing care

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: January 31, 2023
• Est. primary completion date: December 31, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patient aged 18 years or older, who has been informed of the research;

• Patient with a pilonidal cyst treated with Holmium Laser during a scheduled procedure.

Exclusion Criteria:

• Patient under legal protection, guardianship or curatorship;

• Patient who has indicated his opposition to the use of his data.

• Patient undergoing emergency surgery for an abscess

Related Conditions & MeSH terms

• Cysts
• Pilonidal Cyst
• Pilonidal Sinus

Locations

Country	Name	City	State
France	Clinique de la Sauvegarde	Lyon

Sponsors (1)

Lead Sponsor	Collaborator
GCS Ramsay Santé pour l'Enseignement et la Recherche

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Healing rate	explanatory analysis of the healing rate at Month 1	Month 1